How to buy Beyond Air stock

Beyond Air, Inc is a medical devices business based in the US. Beyond Air shares (XAIR) are listed on the NASDAQ and all prices are listed in US Dollars. Beyond Air employs 23 staff and has a trailing 12-month revenue of around 0.00.

Beyond Air share price

Use our graph to track the performance of XAIR stocks over time.

Beyond Air shares at a glance

• Key figures

Information last updated 2021-04-23.

52-week range	$4.65 - $8.90
50-day moving average	$5.65
200-day moving average	$5.74
Wall St. target price	$13.25
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-1.49

Buy Beyond Air shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Beyond Air stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Beyond Air, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Beyond Air financials

Revenue TTM	$530,216
Gross profit TTM	$1.4 million
Return on assets TTM	-67.46%
Return on equity TTM	-156.79%
Profit margin	0%
Book value	$0.86
Market capitalisation	$109 million

TTM: trailing 12 months

Shorting Beyond Air shares

There are currently 2.3 million Beyond Air shares held short by investors – that's known as Beyond Air's "short interest". This figure is 19.9% up from 1.9 million last month.

There are a few different ways that this level of interest in shorting Beyond Air shares can be evaluated.

Beyond Air's "short interest ratio" (SIR)

Beyond Air's "short interest ratio" (SIR) is the quantity of Beyond Air shares currently shorted divided by the average quantity of Beyond Air shares traded daily (recently around 367289.21095008). Beyond Air's SIR currently stands at 6.21. In other words for every 100,000 Beyond Air shares traded daily on the market, roughly 6210 shares are currently held short.

However Beyond Air's short interest can also be evaluated against the total number of Beyond Air shares, or, against the total number of tradable Beyond Air shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Beyond Air's short interest could be expressed as 0.11% of the outstanding shares (for every 100,000 Beyond Air shares in existence, roughly 110 shares are currently held short) or 0.1208% of the tradable shares (for every 100,000 tradable Beyond Air shares, roughly 121 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Beyond Air.

Find out more about how you can short Beyond Air stock.

Beyond Air share dividends

We're not expecting Beyond Air to pay a dividend over the next 12 months.

Beyond Air share price volatility

Over the last 12 months, Beyond Air's shares have ranged in value from as little as $4.651 up to $8.8999. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Beyond Air's is -0.6399. This would suggest that Beyond Air's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Beyond Air has bucked the trend.

Beyond Air overview

Beyond Air, Inc. , a clinical-stage medical device and biopharmaceutical company, develops inhaled nitric oxide (NO) to treat respiratory infections, and gaseous NO to treat solid tumors. The company is developing LungFit system, a NO generator and delivery system, which is in clinical trials for the treatment of lung infections, persistent pulmonary hypertension of the newborn, severe acute respiratory syndrome coronavirus 2, bronchiolitis, and nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. The company is based in Garden City, New York.

Frequently asked questions

What percentage of Beyond Air is owned by insiders or institutions?
Currently 16.621% of Beyond Air shares are held by insiders and 16.118% by institutions. How many people work for Beyond Air?
Latest data suggests 23 work at Beyond Air. When does the fiscal year end for Beyond Air?
Beyond Air's fiscal year ends in March. Where is Beyond Air based?
Beyond Air's address is: 825 East Gate Boulevard, Garden City, NY, United States, 11530 What is Beyond Air's ISIN number?
Beyond Air's international securities identification number is: US08862L1035 What is Beyond Air's CUSIP number?
Beyond Air's Committee on Uniform Securities Identification Procedures number is: 001448109